Jessica Kim, NP
Adult Health · Huntington, NYNPI 1245941046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $742, more than ten times the $19 reported in 2023.
Across 49 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$166
- Phathom Pharmaceuticals, Inc.$161
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$154
- Intra-sana Laboratories$150
- Ardelyx, Inc.$136
- Johnson & Johnson$61
- plus $312 from 8 others
What the payments were for
- Food & beverage$1,140100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $166 |
| Phathom Pharmaceuticals, Inc. | 8 | $161 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $154 |
| Intra-sana Laboratories | 1 | $150 |
| Ardelyx, Inc. | 7 | $136 |
| Johnson & Johnson(2 entities) | 2 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Novo Nordisk | 3 | $55 |
| Pfizer | 2 | $40 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Exact Sciences | 2 | $31 |
| Evoke Pharma, Inc. | 1 | $19 |
| Braintree Laboratories, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reltone 200 Mg$150
- GLYCATE$150
- Reltone 400 Mg$150
How this compares
$1,140 in reported general payments places this provider in the 70th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 17 | $387 |
| Pantoprazole Sodium | 25 | $325 |
| Famotidine | 15 | $210 |
Paid to pharmacies, not to this prescriber.
Other adult health in Huntington
- Silvia TuthillHuntington$43K
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.